Back to search

Article

Alemtuzumab mediates T-regulatory response via macrophagal CD23.

2020-05-11

Abstract excerpt

<h4>Background: </h4> Alemtuzumab (ALM) effectively prevents multiple sclerosis (MS)​ relapses. It causes lymphocytic depletion with subsequent enhancement of T-regulatory cell population. Direct administration of ALM to T-cells causes cytolysis. However, the T-cells may be indirectly affected by myeloid cells, which are resistant to ALM cytotoxicity. Does ALM modulate monocytes? Does the cross-talk between expose...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d028223-157a-528a-9914-9050f06e6666
DOI
10.21203/rs.3.rs-27301/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alemtuzumab mediates T-regulatory response via macrophagal CD23.DOI 10.21203/rs.3.rs-27301/v1
Select a neighboring publication to make it the new centre.